INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4798, 22701, 'Dicloxacillin', 'Certain penicillins may exhibit reduced gastrointestinal absorption in the presence of food.  The therapeutic effect of the antimicrobial may be reduced.', 'food', 'Moderate', '', 'DDInter', 0, X'789c458d410ec2300c04bfb22fe02d1c10773771524b898d1243e9ef311515d7ddd9d9dbca10751e945cb4e2c12a495a13c55cedd9321606e52e2a3328ce30654433a228361836e09b1dd1049580d099dabc00d7bfec0ed20ceaf63e138aad9ac7a470f2102f3b8a593ec04efbf7b8ca8b159b78d81d832b8d0cb7dfc107a0f644ae', NULL, X'789c358dc10dc3300c0357e10459a22b6401d9a61b018964c80ad06e5fe7d12fc9e3bd18296a1834ad7a9e6a13977cc1cfa14513c1765736bc6566b85a72a69a9c90323d46aa1b169e073182935609efe8ee6d03f615af2a64f04ead60efacf90c1e402cf5d21a5e741d3ed6c2bf70fb01640838ed');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4800, 10774, 'Dicyclomine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4801, 10775, 'Dicyclomine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4802, 27350, 'Dicyclomine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4803, 27353, 'Dicyclomine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4805, 3886, 'Dimenhydrinate', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4806, 449, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4807, 3697, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4808, 6926, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4809, 11249, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4810, 14183, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4811, 17194, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4812, 17195, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4813, 17196, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4814, 17230, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4815, 17231, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4816, 17232, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4817, 27095, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4818, 27096, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4819, 27097, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4820, 27997, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4821, 30409, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4822, 30410, 'Diltiazem', 'Like many CNS-active agents, alcohol can exhibit hypotensive effects.  Coadministration with antihypertensive agents including diltiazem may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c4d8e410ec2300c04bfb20f003ed12be2c20bdcc46d2c52bb8a5da0bc9e2084c4796767f72c37c642ba63b85c8f9442ee0c9a59c30fa09aac584522053f8b8c1228fb6ac1ea1f8ea78953f809188cf2222a1e8d424cf19028200de93cb75fe12b8668aa5b169d91a586d08b97fe614763df6af41894b3c4df04ba72ac66196b877c6bdda519d6a29807b9f8e90dc7fe4bfc');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4823, 5824, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4824, 22278, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4825, 22279, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4826, 22324, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4827, 22325, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4828, 27964, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4829, 27965, 'Dimethyl fumarate', 'Food does not significantly affect the oral bioavailability of dimethyl fumarate.  Administration of dimethyl fumarate with a high-fat, high-calorie meal did not affect the systemic exposure (AUC) to its active metabolite, monomethyl fumarate (MMF), but decreased its peak plasma concentration (Cmax) by 40% and prolonged the time to reach peak concentration (Tmax) from 2.0 hours to 5.5 hours.', 'high-fat foods', 'Minor', '', 'DDInter', 0, X'789c25cbcb1180201083e156528063035e6d0435b88ce03ab8c8d0bdaf530eff9731249ab4085f92cbce88e41a26c2dcc61d359840f3b75a0c5e7519205a7931772f0afb8a603f7cebf717c603994b99091fcb298fea6f535e274c', NULL, X'789c6d8fc16ac33010447f652e851852134af30121905b6eed07aca555b454d21a699dc67f5f3ba150426f3bb033f3e6a4eae1951b8a1a9a5c8a0471542ccda010d8192c32b452c2204a5792448324b1191ae025b3c539214c992a19f7c0c16729d26c91a2e5df2f7c8b4510a25ce26b20db3e2e4749ab30322f6d5efc9de90f459b9b711607be8ddaa6cad81c3e8f1d4c21d640cee4baba8d065d08798bac459fbb37e7f3a9db62980c9e5d656aeceffe91e90b63a296094e8be3f2bb6173cc74eb30cc78dfbd808ac7583569b92cce15cc96812bc512e6e223e729e0e31e10aa66bcf53b449d6a5b1dfb7eff10fd0fe0678cdf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4830, 30976, 'Diphenhydramine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4834, 14102, 'Dipyridamole', 'Caffeine and other xanthine derivatives (e.g., theophylline) are nonspecific, competitive antagonists of adenosine receptors.  As such, they may interfere with the vasodilating effect of dipyridamole, an adenosine receptor agonist.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c358d510e02310844afc205f463e341bc0229742569a1016ab2b7174dfc9d99f7e68929ac19102fdb8300df2604cd34f65c29a6601d1af6cea27cab3c5154f484e546bb15d8cd01130663241c0f288f47d552791a20cd02221dff369275b9104e1bfca3e7650d9d04072cf6bee33b948967fddc3f49673ce5', NULL, X'789c6d8e41aec2300c44af324b90aade0171122b711a4bad1dc5a6fff7f6248825dbb1e7cd7b52292cca20cdb0a8dcf14f1a754699bb9c1472b2e3c6ebb62e180fd6eab5efe37e0775869a7ae32445d2826447e3905919c0a0cd543c1c564099d57c623b276e61dd57e0e1f057aa1ff085832e8806f7c283fc2751678e93dcb2ecc34437f0f04d318959dad525d3613b2f63eec704be06eb1b92765576');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4835, 24773, 'Dipyridamole', 'Caffeine and other xanthine derivatives (e.g., theophylline) are nonspecific, competitive antagonists of adenosine receptors.  As such, they may interfere with the vasodilating effect of dipyridamole, an adenosine receptor agonist.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c358d510e02310844afc205f463e341bc0229742569a1016ab2b7174dfc9d99f7e68929ac19102fdb8300df2604cd34f65c29a6601d1af6cea27cab3c5154f484e546bb15d8cd01130663241c0f288f47d552791a20cd02221dff369275b9104e1bfca3e7650d9d04072cf6bee33b948967fddc3f49673ce5', NULL, X'789c6d8e41aec2300c44af324b90aade0171122b711a4bad1dc5a6fff7f6248825dbb1e7cd7b52292cca20cdb0a8dcf14f1a754699bb9c1472b2e3c6ebb62e180fd6eab5efe37e0775869a7ae32445d2826447e3905919c0a0cd543c1c564099d57c623b276e61dd57e0e1f057aa1ff085832e8806f7c283fc2751678e93dcb2ecc34437f0f04d318959dad525d3613b2f63eec704be06eb1b92765576');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4836, 25193, 'Dipyridamole', 'Caffeine and other xanthine derivatives (e.g., theophylline) are nonspecific, competitive antagonists of adenosine receptors.  As such, they may interfere with the vasodilating effect of dipyridamole, an adenosine receptor agonist.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c358d510e02310844afc205f463e341bc0229742569a1016ab2b7174dfc9d99f7e68929ac19102fdb8300df2604cd34f65c29a6601d1af6cea27cab3c5154f484e546bb15d8cd01130663241c0f288f47d552791a20cd02221dff369275b9104e1bfca3e7650d9d04072cf6bee33b948967fddc3f49673ce5', NULL, X'789c6d8e41aec2300c44af324b90aade0171122b711a4bad1dc5a6fff7f6248825dbb1e7cd7b52292cca20cdb0a8dcf14f1a754699bb9c1472b2e3c6ebb62e180fd6eab5efe37e0775869a7ae32445d2826447e3905919c0a0cd543c1c564099d57c623b276e61dd57e0e1f057aa1ff085832e8806f7c283fc2751678e93dcb2ecc34437f0f04d318959dad525d3613b2f63eec704be06eb1b92765576');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4839, 11214, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4840, 11215, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4841, 17133, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c5d914d6ec4300885afc2b295a2b947775df4028c4d122ac7b880a7cded8b3323cdcfce60fb7b8fc7d74ad08d4066c892c8f18f0a708524db992b3a4b855ff61516c546b37676c09a1fcbefce89c056e925fa5449b1941dce047811ce944f001f73106b40d9b1faa1c8064a3f9d95f20418e7dc13e57061b8bcf8b9b18318100be4f1a7a13aa75e50438de701cd57afd10a046ed2abdb40bdba9d8e197ca5d1ef4181ac7d814d2abb28d7e559ffae0a8d148a242ce04ae81bc5344dc52549b118f43322a3a1fae0b9885158bcd103328b0e71c874a122ed803c09bafc7162dfc17a5a010db63d1e5a6f4dc92c763281b96ca1e56c1354eac3c2edcf1b9d96d3110f92858c314e9077bb170db9be4f01c5b28c1ac74d1da7b974ceb10b0f4b874cc588352e2e637511cc35b9cca8ba129efe0140e0d53f', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4842, 17134, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4843, 17748, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4844, 17749, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4845, 17750, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4846, 17751, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4847, 17752, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4848, 18656, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4849, 18657, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4850, 32756, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4851, 32757, 'Docetaxel', 'Coadministration with inhibitors of CYP450 3A4, such as grapefruit juice, may significantly increase the plasma concentrations of docetaxel, which is a substrate of the isoenzyme.  Current data suggest that consumption of large quantities of grapefruit juice inhibit both intestinal and hepatic CYP450 3A4 due to certain compounds present in grapefruit.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'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', NULL, X'789c5d90514ec4300c44af3207a856482c0740bd00bf7c7a13b7316a9c103b5acae9492b1088df68fcde4ce642318b8a792397a2b88b278826b9899766280be6d797ebd3031e9faf13ac870432ac8d2a2fad8be3ad4be009997698ac2a8b0452dff641098dc9189e187523cb845034b07ecb4e7a2c819d3e789b704f32e862a0e1b99d95f8881cf76285f573cf7c01e6deda8020921fc97565f311223ff0d6733d978cc38ddaca78efa38fb8f0e9fbdffc672c6ee55cee03264a1b482312d7d134fcf902c43e0615046e4ea2c3986be91a0db5b11dadc6e3afe3f2053a998115');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4852, 21657, 'Aluminum hydroxide', 'The concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum concentrations, resulting in toxicity.  Citrates or citric acid are contained in numerous soft drinks, citrus fruits, juices, and effervescent and dispersible drug formulations.  Citrates enhance the gastrointestinal absorption of aluminum by an unknown mechanism, which may involve the formation of a soluble aluminum-citrate complex.', 'citrus fruits', 'Major', '', 'DDInter', 0, X'789c4dced10dc2300c04d0556e00c4324c90364e6d29892bdb81767b0208c1d749d6e9f96eda0874ec64e1305ab535ea19c129907aa455b2c35947cde81a58084d0eca784830d4b0c99d3a520932b06c8cdd34483a8a5a1b358568f7cb070ca62f8aac4e5f78a24e7bb214132ea6eddd2c4459fa86e54472b4b1f22b777597a5d2654af9c7c658feb960351d1bd713a50e677a5de7a2f93f37e9e261ef65d727902f5ebe', NULL, X'789c5d915172c3200c44afa2cf76c6f5257a855e0083b0d580e49120896f5fe1b44da77fb0f6ae9e968f0d210a47a9d4023708a91293350d8d84413284d25deaf5cd7f6bc13ff20abb4aeab119bce0bcce13b833444ae68704fb26b66fa1212cc409d55e4f39d20845831a0e305a99324537960388a362300443edf577e20986fccd6213285a2f6d001043933b79e63103bcff448b9e6328c2c081a0e772831ad3f07828aa740393dc2029f1c56387c5b5ac9d9a5f3f3b45b4e984c69c51af6803e31412d9ee2bd152d0fd7d852c5a7b7910fe4541de82d343f382d7e0850ab1eb4e1f0a84c544f7ff0dc372f80ce87c61b931548c1e415627b86d14b7b338e2ab94eb23768c7e3e93ef54fac07a3ed883c52ba87bc1fbfc059f3bb86c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4853, 21657, 'Aluminum hydroxide', 'The concomitant administration of aluminum-containing products (e.g., antacids and phosphate binders) and citrates may significantly increase serum aluminum concentrations, resulting in toxicity.  Citrates or citric acid are contained in numerous soft drinks, citrus fruits, juices, and effervescent and dispersible drug formulations.  Citrates enhance the gastrointestinal absorption of aluminum by an unknown mechanism, which may involve the formation of a soluble aluminum-citrate complex.', 'soft drinks', 'Major', '', 'DDInter', 0, X'789c4dced10dc2300c04d0556e00c4324c90364e6d29892bdb81767b0208c1d749d6e9f96eda0874ec64e1305ab535ea19c129907aa455b2c35947cde81a58084d0eca784830d4b0c99d3a520932b06c8cdd34483a8a5a1b358568f7cb070ca62f8aac4e5f78a24e7bb214132ea6eddd2c4459fa86e54472b4b1f22b777597a5d2654af9c7c658feb960351d1bd713a50e677a5de7a2f93f37e9e261ef65d727902f5ebe', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4855, 28230, 'Dolutegravir', 'Food increases the extent of absorption and slows the rate of absorption of dolutegravir.  When administered with a low-, moderate- or high-fat meal, dolutegravir peak plasma concentration (Cmax) increased by 46%, 52% and 67%, systemic exposure (AUC) increased by 33%, 41% and 66%, and time to reach Cmax (Tmax) increased from 2 hours to 3, 4 and 5 hours, respectively, compared to administration under fasted conditions.', 'food', 'Minor', '', 'DDInter', 0, X'789c73c9cf292d494d2f4a2ccb2c52c84dac54484a552849cc4ecd5328cf2cc950c82f02d3f9a5250a69f9f9297a00a9e81181', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4859, 3876, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4860, 3879, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4861, 4657, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4862, 11132, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4863, 11489, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4864, 11490, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4865, 11491, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4866, 17889, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4867, 17890, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4868, 17891, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4869, 20052, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4870, 29237, 'Doxycycline', 'Chronic alcohol consumption may enhance the elimination of doxycycline.  The mechanism is induction of hepatic microsomal enzymes by alcohol.', 'alcohol', 'Minor', '', 'DDInter', 0, X'789c158ed10dc4200c4357f100d74ed305d290d248942012eed4ed0f7e2c5bb29f7cdc02ad5ff1d04c61dde123e71911374df929cb465ba217c95c6bc633edb946499942d274b32b2e68142a35fc03f126ac54ca0bbd402969a8552a6b357851521fd9415d305cd20e1cf388147db4d2eac22ed8c4768444277eb9681547eb76d2b9b88e6a01ba2ee1f5e27c4185edb602b6eae3690bb3ff018c535346', NULL, X'789c35cddb09c3500c03d055344196e80a5dc0755c6cf023e4261067fa5e0af9d691f4d2bdd218e45c5a0eae1c676c875522a821a9942c3854206e6149ffacbe58eb6a6e764b5980f704213cb58d800d58ae273f56659b3d4618ef352ac8e7f2dd21039f7ece971fb11434c7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4871, 2086, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4872, 2087, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4873, 3865, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4874, 3866, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4875, 3911, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4876, 15865, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4877, 17013, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4878, 17078, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4879, 17847, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4880, 17848, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4881, 17849, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4882, 17866, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4883, 17867, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4884, 17869, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4885, 17872, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4886, 17965, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4887, 18142, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4888, 18143, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4889, 18360, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4890, 18805, 'Doxazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4891, 17912, 'Dronedarone', 'Grapefruit juice may increase the plasma concentrations of dronedarone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  According to the product labeling, administration with grapefruit juice resulted in a 2.5-fold increase in dronedarone peak plasma concentration and a 3-fold increase in systemic exposure.  Because dronedarone is associated with concentration-dependent prolongation of the QT interval, increased levels may potentiate the risk of ventricular arrhythmias such as torsade de pointes and sudden death.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658ed11183300c4357d1001c537480aee012032e899d4b1c28db17e80f77fdd1e943d2d3935c58bdc20b9373c0263e2314530e742aea6c2d06d06a123098d696b28b296cc45428f3589a7877f3783719b803e951d31db5e51c391d98b3ef242a3addf3fcf14283f7c0e31ffc62382dacf0ed58452089fbefa5cf8c64e55a3b59bcf2e51353acfd17688351e2', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4892, 29021, 'Dronedarone', 'Grapefruit juice may increase the plasma concentrations of dronedarone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  According to the product labeling, administration with grapefruit juice resulted in a 2.5-fold increase in dronedarone peak plasma concentration and a 3-fold increase in systemic exposure.  Because dronedarone is associated with concentration-dependent prolongation of the QT interval, increased levels may potentiate the risk of ventricular arrhythmias such as torsade de pointes and sudden death.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658ed11183300c4357d1001c537480aee012032e899d4b1c28db17e80f77fdd1e943d2d3935c58bdc20b9373c0263e2314530e742aea6c2d06d06a123098d696b28b296cc45428f3589a7877f3783719b803e951d31db5e51c391d98b3ef242a3addf3fcf14283f7c0e31ffc62382dacf0ed58452089fbefa5cf8c64e55a3b59bcf2e51353acfd17688351e2', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4893, 29022, 'Dronedarone', 'Grapefruit juice may increase the plasma concentrations of dronedarone.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  According to the product labeling, administration with grapefruit juice resulted in a 2.5-fold increase in dronedarone peak plasma concentration and a 3-fold increase in systemic exposure.  Because dronedarone is associated with concentration-dependent prolongation of the QT interval, increased levels may potentiate the risk of ventricular arrhythmias such as torsade de pointes and sudden death.', 'grapefruit juice', 'Major', '', 'DDInter', 0, X'789c658ed11183300c4357d1001c537480aee012032e899d4b1c28db17e80f77fdd1e943d2d3935c58bdc20b9373c0263e2314530e742aea6c2d06d06a123098d696b28b296cc45428f3589a7877f3783719b803e951d31db5e51c391d98b3ef242a3addf3fcf14283f7c0e31ffc62382dacf0ed58452089fbefa5cf8c64e55a3b59bcf2e51353acfd17688351e2', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4894, 208, 'Doxylamine', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4896, 31974, 'Drospirenone', 'Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c7d8f4b4e04310c44af52271821311c00b160c96c59ba13276d944f2b7666e8dbe30604ac585a65fbbdba90093753dcd68ec179161a6547e84d6765e4411ba731c5d0c7dfe96d4a60e8da67895818b537b13e3822f922c52b0f65704a1cfc39b5082ac647be15d24a0721387838df59e80971ccacb0950cb3451eb94325374912a819b6c1baab719580ca464b2fa215cb8ea7d7cbf9e10ef78fe713f0fceb7850ff51a66b97e842927c13d25c8fc2610351e8d4cdd539facb97412df3f7bd67ad1bf8fd2b86f59f53dcc4562fc0defcb3cce903c9bb8157', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4898, 3229, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4899, 3230, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4900, 3231, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4901, 3232, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4902, 3379, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4903, 4147, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4904, 7214, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4905, 7218, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4906, 11264, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4907, 13552, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4908, 13555, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4909, 17005, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4910, 17297, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4911, 17954, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4912, 17955, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4913, 21253, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4914, 21254, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4915, 23430, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4916, 24683, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4917, 30397, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4918, 30398, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4919, 31896, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4920, 32137, 'Duloxetine', 'Use of duloxetine in conjunction with chronic alcohol consumption may potentiate the risk of liver injury.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65ced10dc2300c84e1556e00c4145d244d0e62b0e22a764abb3ded030889e793beffa64184212ad1c59fb01b545676487b8cbe5fb0a410b6702c9d9ebbcc2c28436d634823bcdad08299c8369a538ff9f0d26a52c02dd3fde0309c279d345b35bd02d31f7167634faa3b9ac509fe040ff1fbe32551e163f6482d24e9073d1bd73738a54d37', NULL, X'789c1dccd10d80200c05c055de046ee300a4d650c4964051d95ef1ff726b63d88ead677bd84519a220d3d4955c4c718b4750aca64208992c5a9ea0f5b3fce00c03c59cd52538c323a34a3be69ae5e2fa85a9d7b1bc6850282c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4921, 28586, 'Dulaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4922, 28587, 'Dulaglutide', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.  Episodes of hypoglycemia may last for 8 to 12 hours after ethanol ingestion.  By contrast, chronic alcohol abuse can cause impaired glucose tolerance and hyperglycemia.  Moderate alcohol consumption generally does not affect blood glucose levels in patients with well controlled diabetes.  A disulfiram-like reaction (e.g., flushing, headache, and nausea) to alcohol has been reported frequently with the use of chlorpropamide and very rarely with other sulfonylureas.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4924, 14247, 'Efavirenz', 'Administration with food increases the plasma concentrations of efavirenz and may increase the frequency of adverse reactions.  According to the product labeling, administration of efavirenz capsules (600 mg single dose) with a high-fat/high-caloric meal (894 kcal, 54 g fat, 54% calories from fat) or a reduced-fat/normal-caloric meal (440 kcal, 2 g fat, 4% calories from fat) was associated with mean increases of 39% and 51% in efavirenz peak plasma concentration (Cmax) and 22% and 17% in systemic exposure (AUC), respectively, compared to administration under fasted conditions.  For efavirenz tablets, administration of a single 600 mg dose with a high-fat/high-caloric meal (approximately 1000 kcal, 500-600 kcal from fat) resulted in a 79% increase in mean Cmax and a 28% increase in mean AUC of efavirenz relative to administration under fasted conditions.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c5d91518edb300c44afc20318fbb1e811daff5e8191e88888241aa46cc339fd8e9262b1e887608894876f867f563ed4a53f298aed35d34d68f0433a5927ee246d1b17c5b0c6a92cb4b9ace27cab17f1c0db3cb4c907d16f0bedf71f356a7c91b6cded8060c1b13a7fd4aad0b395baf8617b505c31a4e18341d670df53210ecafa7c6a978885b487b5aebc4c41066da6643d491fce43ad2f34fbd0476d21be75f3c695b20b43907ba6c2b5ee49fbeb3914b90eb8bd9749366906fcba8455c0c237aaea64271240cb5ffcab7a0cfa840ffa45a7c823a60b749cb78b10c15f8803297e04c9f9d000edfb216d86394381b69aa399752806be8dd4ff1391759504b9b3004ebed7a4417bfc4bc09a0eee03cb387520b59aac5825886f71a5629c5e03b2eff7691a41809e0fd38c9a1e7363786b9bcc1c7129fc64cf93616e1be9fb453b88eb3ba747b7930ace34d3246b7ae58990dea428b78f2fc86ddc34', NULL, X'789c9552cb6e02310cfc155f90408276a150e0882af50ffa0126f142441edb384bd97e7d9d2cb45071686f89ed998c67b2d1ce78c3296232c1c387497ba843d060bc8a844c0c694fd0586487a08257e4cfc30ca106aaf16822f94f40afc161f70d2cb83ad27b4b5e757916f591a234a4ad0ac103c046a910b5f13b48a17f2906ddaa0416b764a53e16d88dc49b471536dc5a11397cae2a703b608158021d9846fd36087bb3db4f6a4c8fe5a0d086681438420bc3d57a0e07298d6131871dc8543e0da09f12e23a0697cb230851b822893ad285ce87e8d0fe229ccfab33e1ecc2779fee0319903928838974af5528fc95f3b2ead37a509c5d4c07d2b8dabc213cdc8d05862f0e4fa3829acd7af47459d0dc71222752e9d4046e23c170f3f6321acb56dc90647224db8d85ce35288be6487e99df7a4d51f473962ccf6a7309f255ecf95197706b29f1bdf0f092d139b11cd55f92c246bec6c93871cb7630adaa8bcf8baa9a3c9f6f57feca4eadcd32657184e57af0f333a5529cce46157f1066ab3b7d31e7f6bb45b2985dfa87335f2cfc2df2');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4926, 25974, 'Eltrombopag', 'Food may reduce the oral bioavailability of eltrombopag.  In healthy volunteers, a standard high-fat breakfast significantly decreased plasma eltrombopag peak plasma concentration (Cmax) by 65% and systemic exposure (AUC) by 59% and delayed Tmax by one hour.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c7d8ec16d03310c045bd9020e7e1869200f17424bbc1c1d4a14445e82ebdeb461c0c827dfe1ec2e2f1ad3dad5067dc137dbb5e2ca08fae60eeba00e6e230e7858a3b22563a436d35a6d326c227eed891cb4064f101a939e80cf5a25c43aa91e0bf89f250a289307ceafa677fbc7dfee7e604cab7b09476c992bd683a463981e3fa4dc13d163d5e17b3e4c194da348f5054d3a4fd2bc8ca1dc524e5849e6bb7549bd22d74356e18adb2e85fd7407addb6c99', NULL, X'789c4d8dc14a433110457fe56e840ada5d05975210dceb074c92792f83c9cc2399579abf37b5086ecfbd87f36e965069a071da23c333c31a150431ba90140a52c4076c01176f56836db41e810f45662a9e072e567675e6d69f40e84e9aa8256459f3f3428ed098be17ea8e2eabca2291d4cb40e23897ce095ba15ee97f01db74fe78348dacdec8c5148773a5eb23c2c0cbe90133863eba739508be6ed6f7c638bc7d9d7f2fa7d7fb2571a1314b9fd3bd715346b6bd1d7f00e0f75caf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4927, 25975, 'Eltrombopag', 'Food may reduce the oral bioavailability of eltrombopag.  In healthy volunteers, a standard high-fat breakfast significantly decreased plasma eltrombopag peak plasma concentration (Cmax) by 65% and systemic exposure (AUC) by 59% and delayed Tmax by one hour.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c7d8ec16d03310c045bd9020e7e1869200f17424bbc1c1d4a14445e82ebdeb461c0c827dfe1ec2e2f1ad3dad5067dc137dbb5e2ca08fae60eeba00e6e230e7858a3b22563a436d35a6d326c227eed891cb4064f101a939e80cf5a25c43aa91e0bf89f250a289307ceafa677fbc7dfee7e604cab7b09476c992bd683a463981e3fa4dc13d163d5e17b3e4c194da348f5054d3a4fd2bc8ca1dc524e5849e6bb7549bd22d74356e18adb2e85fd7407addb6c99', NULL, X'789c4d8dc14a433110457fe56e840ada5d05975210dceb074c92792f83c9cc2399579abf37b5086ecfbd87f36e965069a071da23c333c31a150431ba90140a52c4076c01176f56836db41e810f45662a9e072e567675e6d69f40e84e9aa8256459f3f3428ed098be17ea8e2eabca2291d4cb40e23897ce095ba15ee97f01db74fe78348dacdec8c5148773a5eb23c2c0cbe90133863eba739508be6ed6f7c638bc7d9d7f2fa7d7fb2571a1314b9fd3bd715346b6bd1d7f00e0f75caf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4928, 29183, 'Eltrombopag', 'Food may reduce the oral bioavailability of eltrombopag.  In healthy volunteers, a standard high-fat breakfast significantly decreased plasma eltrombopag peak plasma concentration (Cmax) by 65% and systemic exposure (AUC) by 59% and delayed Tmax by one hour.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c7d8ec16d03310c045bd9020e7e1869200f17424bbc1c1d4a14445e82ebdeb461c0c827dfe1ec2e2f1ad3dad5067dc137dbb5e2ca08fae60eeba00e6e230e7858a3b22563a436d35a6d326c227eed891cb4064f101a939e80cf5a25c43aa91e0bf89f250a289307ceafa677fbc7dfee7e604cab7b09476c992bd683a463981e3fa4dc13d163d5e17b3e4c194da348f5054d3a4fd2bc8ca1dc524e5849e6bb7549bd22d74356e18adb2e85fd7407addb6c99', NULL, X'789c4d8dc14a433110457fe56e840ada5d05975210dceb074c92792f83c9cc2399579abf37b5086ecfbd87f36e965069a071da23c333c31a150431ba90140a52c4076c01176f56836db41e810f45662a9e072e567675e6d69f40e84e9aa8256459f3f3428ed098be17ea8e2eabca2291d4cb40e23897ce095ba15ee97f01db74fe78348dacdec8c5148773a5eb23c2c0cbe90133863eba739508be6ed6f7c638bc7d9d7f2fa7d7fb2571a1314b9fd3bd715346b6bd1d7f00e0f75caf');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4929, 25974, 'Eltrombopag', 'Food may reduce the oral bioavailability of eltrombopag. The calcium content of this meal may have also contributed to this decrease in exposure.  In another study, adult subjects administered a single 25 mg dose of eltrombopag for oral suspension with a high-calcium, moderate-fat, moderate-calorie meal exhibited a 79% decrease in Cmax and 75% decrease in AUC of eltrombopag.  Administration of eltrombopag 2 hours after the high-calcium meal decreased eltrombopag Cmax by 48% and AUC by 47%, while administration 2 hours before the high-calcium meal decreased eltrombopag Cmax by 14% and AUC by 20%.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c7d8ec16d03310c045bd9020e7e1869200f17424bbc1c1d4a14445e82ebdeb461c0c827dfe1ec2e2f1ad3dad5067dc137dbb5e2ca08fae60eeba00e6e230e7858a3b22563a436d35a6d326c227eed891cb4064f101a939e80cf5a25c43aa91e0bf89f250a289307ceafa677fbc7dfee7e604cab7b09476c992bd683a463981e3fa4dc13d163d5e17b3e4c194da348f5054d3a4fd2bc8ca1dc524e5849e6bb7549bd22d74356e18adb2e85fd7407addb6c99', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4930, 25975, 'Eltrombopag', 'Food may reduce the oral bioavailability of eltrombopag. The calcium content of this meal may have also contributed to this decrease in exposure.  In another study, adult subjects administered a single 25 mg dose of eltrombopag for oral suspension with a high-calcium, moderate-fat, moderate-calorie meal exhibited a 79% decrease in Cmax and 75% decrease in AUC of eltrombopag.  Administration of eltrombopag 2 hours after the high-calcium meal decreased eltrombopag Cmax by 48% and AUC by 47%, while administration 2 hours before the high-calcium meal decreased eltrombopag Cmax by 14% and AUC by 20%.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c7d8ec16d03310c045bd9020e7e1869200f17424bbc1c1d4a14445e82ebdeb461c0c827dfe1ec2e2f1ad3dad5067dc137dbb5e2ca08fae60eeba00e6e230e7858a3b22563a436d35a6d326c227eed891cb4064f101a939e80cf5a25c43aa91e0bf89f250a289307ceafa677fbc7dfee7e604cab7b09476c992bd683a463981e3fa4dc13d163d5e17b3e4c194da348f5054d3a4fd2bc8ca1dc524e5849e6bb7549bd22d74356e18adb2e85fd7407addb6c99', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4931, 29183, 'Eltrombopag', 'Food may reduce the oral bioavailability of eltrombopag. The calcium content of this meal may have also contributed to this decrease in exposure.  In another study, adult subjects administered a single 25 mg dose of eltrombopag for oral suspension with a high-calcium, moderate-fat, moderate-calorie meal exhibited a 79% decrease in Cmax and 75% decrease in AUC of eltrombopag.  Administration of eltrombopag 2 hours after the high-calcium meal decreased eltrombopag Cmax by 48% and AUC by 47%, while administration 2 hours before the high-calcium meal decreased eltrombopag Cmax by 14% and AUC by 20%.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c7d8ec16d03310c045bd9020e7e1869200f17424bbc1c1d4a14445e82ebdeb461c0c827dfe1ec2e2f1ad3dad5067dc137dbb5e2ca08fae60eeba00e6e230e7858a3b22563a436d35a6d326c227eed891cb4064f101a939e80cf5a25c43aa91e0bf89f250a289307ceafa677fbc7dfee7e604cab7b09476c992bd683a463981e3fa4dc13d163d5e17b3e4c194da348f5054d3a4fd2bc8ca1dc524e5849e6bb7549bd22d74356e18adb2e85fd7407addb6c99', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4934, 5950, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4935, 5951, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4936, 13589, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4937, 15125, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4938, 16503, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4939, 17527, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4940, 17548, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4941, 17549, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4942, 18278, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4943, 18279, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4944, 18286, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4945, 19565, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4946, 19847, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c5590db4d04310c455b7101400f7c2051000d783277124b4e3cc4c92ed33d8ed022f88af23af7f8be6ab2624a952f4a3c1d54aed3b25e095598acaf3dfaef81343a7908da70bacb28b40b6f18f017a2f7bf3fabf9a0a3e373c65bbdc8529add699f5d5a264e738092359ff51c628dec20fe7109d2db0d2d083b82c1d5e64a4bdc48ed8e4e9b9aede433732797dce490b88c9027829f48c21a81f7128c51f0c09278d8e74062a7080c1c22fb221f56399535eb611a114b105fe8491c21f3118c8a54b889d740dc4c6f58ac229b3cdc378b2eb2ce180996d1e011c7d11154d7ba44d21a04fdb9234fe561fda21ec2510268d8bfe25fbe0143e09936');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4947, 19848, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4948, 20077, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4949, 21143, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4950, 21144, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4951, 22496, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4952, 22497, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4953, 26749, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4954, 28541, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4955, 30597, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4956, 30598, 'Empagliflozin', 'Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c65914b6ec3300c44af32cb160802a440975df406bd822c31111b9a34243aae7bfa4a8e51f4b311040c86f3867c0bcea45eb1b067240e033955d46cb324849b714234adf3c87a419068d9047c8667e28241cc122e3247ab04ae50732c24d24d5e4c84d2015676c78a1c6e84bc4e54bcf045d64885138d1c0e509a8b4dc1f3ba39a6a0b150c373ae47e0ed17e89f887fe0c223fbcef80dad1eae043798125261bd22059615e716b7d8488aa009bed85dad3fe42e3e9c76d70b9e619f8d44e980d353ff0f4465c33e1d372d7175ded0eac485bd3eb6fc4efc3e6b7436bdf7b813aa953148cb68cf24415bddd71d7aefd3d73ad07e8936d43a2a689c7c45751b43cc3dfcdcb6614bbf147d50895ce9f8057ecaaedb', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4957, 35, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4958, 36, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4959, 4167, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4960, 4588, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4961, 4591, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4962, 4605, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4963, 8030, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4964, 18295, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4965, 25189, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4966, 25190, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4967, 25195, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4968, 25196, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4969, 25871, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4970, 25872, 'Enalapril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4971, 35, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4972, 36, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4973, 4167, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4974, 4588, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4975, 4591, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4976, 4605, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4977, 8030, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4978, 18295, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4979, 25189, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4980, 25190, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4981, 25195, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4982, 25196, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4983, 25871, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4984, 25872, 'Enalapril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4985, 2834, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4986, 11225, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4987, 11226, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4988, 14915, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4989, 14916, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4990, 15952, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4991, 16572, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4992, 18335, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4993, 18336, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4994, 18337, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4995, 20333, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4996, 20334, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4997, 22103, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4998, 22104, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'789c6d90dd4e02410c855fe5dc9068021b24a0de1212dfc007e8ce1476e2fc6c3a5d94b7b73b9048d4bbfe7e3d3d6fa578788e74a9d081518422a8af45460d2583b287b09f1cdff5fb50e84c21521f62d00bca119c951d9d8374c0deb9223ee413b4b4a5518a1114b6c0d1ea4b904f2187aa42edca3d00eb6e8774c267d00184aa2681c46308a761752445629350c47ad14ab75cb84e51d92398e6eb432dfcf9a4bf1879b39b35adbb971d8632495db661274c95e7f9a696e90363a49a08ae6467ca6e321f0e89be1e67d276bb9841dbe7c5b259f497429661ca9ee50afd87b7d290186e9233e361ff7e68e4a7d746deac17369c46c3f839ff65d8edc891aace3e9b49cadd370578a0c1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (4999, 27960, 'Entecavir', 'Food delays the oral absorption and reduces the oral bioavailability of entecavir.  According to the product labeling, administration of entecavir 0.5 mg with a standard high-fat meal or a light meal resulted in a delay in absorption by 0.25 to 0.75 hours, a decrease in the peak plasma concentration (Cmax) by 44% to 46%, and a decrease in the area under the plasma concentration-time curve (AUC) by 18% to 20% compared to administration in the fasting state.', 'high-fat foods', 'Moderate', '', 'DDInter', 0, X'789c3d8dc10dc3300c0357e100451f9da50bc831031bb0a4c0528a74fbba7df4c3cf1dc9a78316e72454aeae32e0738594f0796477bb2d9edce4d527a2f9392a0a2155bbf5484e56b8410cd423df887495ad411283128907566906645f3204caefbcd53f28dc7ddd67238c57fe84fb0788b336ad', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5001, 16696, 'Entacapone', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5002, 24580, 'Entacapone', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5004, 2098, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5005, 2099, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5006, 6717, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5007, 7485, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5008, 18477, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5009, 18478, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5010, 18496, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5011, 18497, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5012, 28034, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5013, 28035, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5014, 33755, 'Eplerenone', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5015, 22120, 'Erlotinib', 'Grapefruit and grapefruit juice may increase the plasma concentrations of erlotinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f310ec2300c45aff22f0042020e801858195818ddd4a546891dc5ae506f4fcac268eb3d7fff5ba3ca535b24403ae2f51fdf8b2446a115a2a93139236646cde485904c136b340a3175d8046ed94254863df0d8c066d59c47144e33a9788178bf35cb209bb439d7e7fd743ee07839ed0a8f42d1f1499ac7ae927b378306cb3f557fe9af25f0a19c31ac48dc82fa3e59a9b6e8e83d92bd3fb5c1ff22fb2f4243535b');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (5016, 27904, 'Erlotinib', 'Grapefruit and grapefruit juice may increase the plasma concentrations of erlotinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c458f310ec2300c45aff22f0042020e801858195818ddd4a546891dc5ae506f4fcac268eb3d7fff5ba3ca535b24403ae2f51fdf8b2446a115a2a93139236646cde485904c136b340a3175d8046ed94254863df0d8c066d59c47144e33a9788178bf35cb209bb439d7e7fd743ee07839ed0a8f42d1f1499ac7ae927b378306cb3f557fe9af25f0a19c31ac48dc82fa3e59a9b6e8e83d92bd3fb5c1ff22fb2f4243535b');